Drug Shortage Report for ACTONEL
Report ID | 5831 |
Drug Identification Number | 02242518 |
Brand name | ACTONEL |
Common or Proper name | ACTONEL 5MG |
Company Name | ALLERGAN PHARMA CO. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28 COUNT |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-08-01 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-12-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-08-02 | English | Compare |
v3 | 2017-10-04 | English | Compare |
v2 | 2017-04-06 | French | Compare |
v1 | 2017-04-06 | English | Compare |
Showing 1 to 4 of 4